These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10855379)

  • 21. New dosage-reduction regime to avoid paroxetine discontinuation syndrome.
    Pacheco Yáñez L; Malo P; Etxebeste M; Aragües E; Medrano J
    Can J Psychiatry; 2003 Mar; 48(2):129-30. PubMed ID: 12655918
    [No Abstract]   [Full Text] [Related]  

  • 22. Newer antidepressants and the discontinuation syndrome.
    Haddad P
    J Clin Psychiatry; 1997; 58 Suppl 7():17-21; discussion 22. PubMed ID: 9219489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delirium following abrupt discontinuation of fluoxetine.
    Blum D; Maldonado J; Meyer E; Lansberg M
    Clin Neurol Neurosurg; 2008 Jan; 110(1):69-70. PubMed ID: 17913343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paroxetine discontinuation syndrome in association with sertindole therapy.
    Walker-Kinnear M; McNaughton S
    Br J Psychiatry; 1997 Apr; 170():389. PubMed ID: 9246265
    [No Abstract]   [Full Text] [Related]  

  • 25. Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors.
    Frost L; Lal S
    Am J Psychiatry; 1995 May; 152(5):810. PubMed ID: 7726327
    [No Abstract]   [Full Text] [Related]  

  • 26. Withdrawal syndromes after paroxetine and sertraline discontinuation.
    Fava GA; Grandi S
    J Clin Psychopharmacol; 1995 Oct; 15(5):374-5. PubMed ID: 8830071
    [No Abstract]   [Full Text] [Related]  

  • 27. Discontinuation symptoms and SSRIs.
    Pollock BG
    J Clin Psychiatry; 1998 Oct; 59(10):535-7. PubMed ID: 9818635
    [No Abstract]   [Full Text] [Related]  

  • 28. Withdrawal syndrome associated with abrupt discontinuation of SSRIs.
    Wincor MZ
    J Am Pharm Assoc (Wash); 1998; 38(4):500-1. PubMed ID: 9707961
    [No Abstract]   [Full Text] [Related]  

  • 29. Re: Depression, stroke diagnosis, and SSRI discontinuation syndrome.
    Haddad PM; Dursun SM
    Can J Psychiatry; 2004 May; 49(5):343-4; author reply 345-6. PubMed ID: 15198473
    [No Abstract]   [Full Text] [Related]  

  • 30. Similar discontinuation symptoms for withdrawal from medium-dose paroxetine and venlafaxine after nine years in the same patient.
    Kotzalidis GD; de Pisa E; Patrizi B; Savoja V; Ruberto G; Girardi P
    J Psychopharmacol; 2008 Jul; 22(5):581-4. PubMed ID: 18208915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria.
    Black K; Shea C; Dursun S; Kutcher S
    J Psychiatry Neurosci; 2000 May; 25(3):255-61. PubMed ID: 10863885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SSRI withdrawal.
    Mareth TR; Brown TM
    J Clin Psychiatry; 1996 Jul; 57(7):310. PubMed ID: 8666577
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical management of antidepressant discontinuation.
    Rosenbaum JF; Zajecka J
    J Clin Psychiatry; 1997; 58 Suppl 7():37-40. PubMed ID: 9219493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system.
    Stahl MM; Lindquist M; Pettersson M; Edwards IR; Sanderson JH; Taylor NF; Fletcher AP; Schou JS
    Eur J Clin Pharmacol; 1997; 53(3-4):163-9. PubMed ID: 9476026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential withdrawal syndrome associated with SSRI discontinuation.
    Lazowick AL; Levin GM
    Ann Pharmacother; 1995 Dec; 29(12):1284-85. PubMed ID: 8672834
    [No Abstract]   [Full Text] [Related]  

  • 36. Serotonin discontinuation syndrome: does it really exist?
    Nuss S; Kincaid CR
    W V Med J; 2000; 96(2):405-7. PubMed ID: 10771628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation.
    Bogetto F; Bellino S; Revello RB; Patria L
    CNS Drugs; 2002; 16(4):273-83. PubMed ID: 11945110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lhermitte's sign in paroxetine withdrawal.
    Reeves RR; Pinkofsky HB
    J Clin Psychopharmacol; 1996 Oct; 16(5):411-2. PubMed ID: 8889917
    [No Abstract]   [Full Text] [Related]  

  • 40. Postoperative delirium indicating an adverse drug interaction involving the selective serotonin reuptake inhibitor, paroxetine?
    Stanford BJ; Stanford SC
    J Psychopharmacol; 1999; 13(3):313-7. PubMed ID: 10512094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.